HEADER OXIDOREDUCTASE 20-OCT-14 4D32 TITLE STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME DOMAIN TITLE 2 IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-(5-METHYL-1H- TITLE 3 IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYLPROPAN-1-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, BRAIN; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, RESIDUES 297-718; COMPND 5 SYNONYM: BNOS, CONSTITUTIVE NOS, NC-NOS, NOS TYPE I, NEURONAL NOS, COMPND 6 N-NOS, NNOS, PEPTIDYL-CYSTEINE S-NITROSYLASE NOS1, NEURONAL NITRIC COMPND 7 OXIDE SYNTHASE; COMPND 8 EC: 1.14.13.39; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR H.LI,T.L.POULOS REVDAT 2 04-MAR-15 4D32 1 JRNL REVDAT 1 24-DEC-14 4D32 0 JRNL AUTH P.MUKHERJEE,H.LI,I.SEVRIOUKOVA,G.CHREIFI,P.MARTASEK, JRNL AUTH 2 L.J.ROMAN,T.L.POULOS,R.B.SILVERMAN JRNL TITL NOVEL 2,4-DISUBSTITUTED PYRIMIDINES AS POTENT, SELECTIVE, JRNL TITL 2 AND CELL-PERMEABLE INHIBITORS OF NEURONAL NITRIC OXIDE JRNL TITL 3 SYNTHASE. JRNL REF J.MED.CHEM. V. 58 1067 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25489882 JRNL DOI 10.1021/JM501719E REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.103 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 38.573 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.88 REMARK 3 COMPLETENESS FOR RANGE (%) : 78.96 REMARK 3 NUMBER OF REFLECTIONS : 44379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1957 REMARK 3 R VALUE (WORKING SET) : 0.1922 REMARK 3 FREE R VALUE : 0.2614 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.9 REMARK 3 FREE R VALUE TEST SET COUNT : 2177 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 38.5799 - 5.2945 1.00 3584 179 0.1434 0.1808 REMARK 3 2 5.2945 - 4.2041 1.00 3388 199 0.1264 0.2007 REMARK 3 3 4.2041 - 3.6731 1.00 3359 172 0.1383 0.2434 REMARK 3 4 3.6731 - 3.3375 1.00 3374 183 0.1683 0.2379 REMARK 3 5 3.3375 - 3.0984 1.00 3323 166 0.2090 0.2566 REMARK 3 6 3.0984 - 2.9158 1.00 3319 190 0.2236 0.2752 REMARK 3 7 2.9158 - 2.7698 1.00 3318 176 0.2268 0.3158 REMARK 3 8 2.7698 - 2.6492 1.00 3326 158 0.2464 0.3605 REMARK 3 9 2.6492 - 2.5473 1.00 3297 172 0.2505 0.2992 REMARK 3 10 2.5473 - 2.4594 0.94 3085 151 0.2752 0.4076 REMARK 3 11 2.4594 - 2.3825 0.79 2634 135 0.2929 0.3858 REMARK 3 12 2.3825 - 2.3144 0.66 2159 104 0.3037 0.3313 REMARK 3 13 2.3144 - 2.2535 0.47 1545 92 0.3226 0.3704 REMARK 3 14 2.2535 - 2.1985 0.34 1130 51 0.3123 0.4346 REMARK 3 15 2.1985 - 2.1485 0.25 817 33 0.3346 0.4655 REMARK 3 16 2.1485 - 2.1028 0.16 544 16 0.4342 0.5449 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.32 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.90 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 30.14 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 7053 REMARK 3 ANGLE : 1.172 9599 REMARK 3 CHIRALITY : 0.077 991 REMARK 3 PLANARITY : 0.005 1212 REMARK 3 DIHEDRAL : 15.199 2573 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID 299:716) REMARK 3 ORIGIN FOR THE GROUP (A): 11.2644 4.7849 22.5945 REMARK 3 T TENSOR REMARK 3 T11: 0.1882 T22: 0.0131 REMARK 3 T33: 0.0927 T12: -0.0068 REMARK 3 T13: 0.0202 T23: 0.0049 REMARK 3 L TENSOR REMARK 3 L11: 1.0155 L22: 1.1645 REMARK 3 L33: 5.8439 L12: -0.2179 REMARK 3 L13: -0.5104 L23: 0.3241 REMARK 3 S TENSOR REMARK 3 S11: -0.0319 S12: 0.2215 S13: -0.0065 REMARK 3 S21: 0.1567 S22: -0.1413 S23: 0.0232 REMARK 3 S31: 0.0909 S32: -0.3117 S33: 0.0557 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN B AND RESID 299:718) REMARK 3 ORIGIN FOR THE GROUP (A): 12.3606 4.9711 60.0961 REMARK 3 T TENSOR REMARK 3 T11: 0.0490 T22: 0.0680 REMARK 3 T33: 0.1132 T12: 0.0812 REMARK 3 T13: 0.0432 T23: -0.0007 REMARK 3 L TENSOR REMARK 3 L11: 0.7614 L22: 1.3625 REMARK 3 L33: 3.6269 L12: -0.3152 REMARK 3 L13: -0.0609 L23: 0.3182 REMARK 3 S TENSOR REMARK 3 S11: -0.0435 S12: 0.0538 S13: 0.0948 REMARK 3 S21: -0.2213 S22: -0.1012 S23: -0.0058 REMARK 3 S31: 0.1536 S32: 0.0994 S33: -0.0000 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESIDUES 339 TO 349 IN CHAIN A REMARK 3 AND 339 TO 347 IN CHAIN B ARE DISORDERED. REMARK 4 REMARK 4 4D32 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-14. REMARK 100 THE PDBE ID CODE IS EBI-62006. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.127 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD (Q315R) REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56167 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.10 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 5.0 REMARK 200 R MERGE (I) : 0.13 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.70 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 4.9 REMARK 200 R MERGE FOR SHELL (I) : 1.50 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.60 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: RMERGE 3.619 RPIM 1.767 CC ONE HALF 0.413 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.1 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-24% PEG3350, 0.1M MES, 10% REMARK 280 ETHYLENE GLYCOL, 140-200 MM AMMONIUM ACETATE, 5 MM GSH, 35UM REMARK 280 SDS REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.82500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 82.22000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.77000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 82.22000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.82500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.77000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9740 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 33050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -86.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 CYS A 297 REMARK 465 PRO A 298 REMARK 465 SER A 339 REMARK 465 GLN A 340 REMARK 465 HIS A 341 REMARK 465 THR A 342 REMARK 465 ARG A 343 REMARK 465 LYS A 344 REMARK 465 PRO A 345 REMARK 465 GLU A 346 REMARK 465 ASP A 347 REMARK 465 VAL A 348 REMARK 465 ARG A 349 REMARK 465 GLY A 718 REMARK 465 CYS B 297 REMARK 465 PRO B 298 REMARK 465 SER B 339 REMARK 465 GLN B 340 REMARK 465 HIS B 341 REMARK 465 THR B 342 REMARK 465 ARG B 343 REMARK 465 LYS B 344 REMARK 465 PRO B 345 REMARK 465 GLU B 346 REMARK 465 ASP B 347 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 717 CA C O CB CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O GLN B 478 O HOH B 2105 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 390 -70.70 -73.81 REMARK 500 SER A 392 -26.78 72.80 REMARK 500 THR A 393 -169.33 -114.04 REMARK 500 ARG A 418 -4.28 -54.13 REMARK 500 LYS A 423 70.63 -103.62 REMARK 500 THR A 466 -81.55 -114.95 REMARK 500 PHE A 517 56.76 -114.39 REMARK 500 ASN A 527 29.71 43.55 REMARK 500 CYS A 582 55.54 -151.95 REMARK 500 ARG A 603 -134.00 -127.85 REMARK 500 ASP B 309 10.25 58.79 REMARK 500 SER B 392 -0.57 73.22 REMARK 500 THR B 466 -78.42 -110.70 REMARK 500 ARG B 481 147.57 -172.11 REMARK 500 CYS B 582 50.05 -154.55 REMARK 500 ARG B 603 -141.88 -131.22 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 7F5 A 800 N01 REMARK 620 2 HEM A 750 NA 85.8 REMARK 620 3 HEM A 750 ND 88.0 90.6 REMARK 620 4 HEM A 750 NC 86.1 171.9 89.3 REMARK 620 5 CYS A 415 SG 172.3 99.7 97.2 88.3 REMARK 620 6 HEM A 750 NB 79.5 89.7 167.4 88.6 95.2 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 750 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM B 750 NB REMARK 620 2 HEM B 750 NA 91.5 REMARK 620 3 HEM B 750 NC 84.6 176.1 REMARK 620 4 HEM B 750 ND 175.7 89.8 94.1 REMARK 620 5 7F5 B 800 N01 82.7 95.5 84.8 93.1 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 900 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 326 SG REMARK 620 2 CYS A 331 SG 113.0 REMARK 620 3 CYS B 326 SG 119.9 101.9 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7F5 A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 750 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 760 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 7F5 B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 900 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D2Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(R,S)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D30 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4D31 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D33 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH (N1-(2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2 REMARK 900 -DIAMINE REMARK 900 RELATED ID: 4D34 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL REMARK 900 )PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D35 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D36 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D37 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITHN-{[(1R,2R)-2-(3- REMARK 900 FLUOROPHENYL)CYCLOPROPYL]METHYL}-2-[2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL]ETHANAMINE REMARK 900 RELATED ID: 4D38 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D39 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D3A RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2 REMARK 900 -(2-(5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL) REMARK 900 ETHYLPROPAN-1-AMINE REMARK 900 RELATED ID: 4D3B RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N1-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2- REMARK 900 DIAMINE REMARK 900 RELATED ID: 4V3U RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3V RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-(2-(1H-IMIDAZOL-1-YL)-4- REMARK 900 PYRIMIDYLMETHYL)-3-(3-FLUOROPHENYL)PROPAN-1-AMINE REMARK 900 RELATED ID: 4V3W RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4V3X RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(2-(3-FLUOROPHENYL)CYCLOPROPYLMETHYL) REMARK 900 ETHAN-1-AMINE DBREF 4D32 A 297 718 UNP P29476 NOS1_RAT 297 718 DBREF 4D32 B 297 718 UNP P29476 NOS1_RAT 297 718 SEQRES 1 A 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 A 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 A 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 A 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 A 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 A 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 A 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 A 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 A 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 A 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 A 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 A 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 A 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 A 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 A 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 A 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 A 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 A 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 A 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 A 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 A 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 A 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 A 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 A 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 A 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 A 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 A 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 A 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 A 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 A 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 A 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 A 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 A 422 THR HIS VAL TRP LYS GLY SEQRES 1 B 422 CYS PRO ARG PHE LEU LYS VAL LYS ASN TRP GLU THR ASP SEQRES 2 B 422 VAL VAL LEU THR ASP THR LEU HIS LEU LYS SER THR LEU SEQRES 3 B 422 GLU THR GLY CYS THR GLU HIS ILE CYS MET GLY SER ILE SEQRES 4 B 422 MET LEU PRO SER GLN HIS THR ARG LYS PRO GLU ASP VAL SEQRES 5 B 422 ARG THR LYS ASP GLN LEU PHE PRO LEU ALA LYS GLU PHE SEQRES 6 B 422 LEU ASP GLN TYR TYR SER SER ILE LYS ARG PHE GLY SER SEQRES 7 B 422 LYS ALA HIS MET ASP ARG LEU GLU GLU VAL ASN LYS GLU SEQRES 8 B 422 ILE GLU SER THR SER THR TYR GLN LEU LYS ASP THR GLU SEQRES 9 B 422 LEU ILE TYR GLY ALA LYS HIS ALA TRP ARG ASN ALA SER SEQRES 10 B 422 ARG CYS VAL GLY ARG ILE GLN TRP SER LYS LEU GLN VAL SEQRES 11 B 422 PHE ASP ALA ARG ASP CYS THR THR ALA HIS GLY MET PHE SEQRES 12 B 422 ASN TYR ILE CYS ASN HIS VAL LYS TYR ALA THR ASN LYS SEQRES 13 B 422 GLY ASN LEU ARG SER ALA ILE THR ILE PHE PRO GLN ARG SEQRES 14 B 422 THR ASP GLY LYS HIS ASP PHE ARG VAL TRP ASN SER GLN SEQRES 15 B 422 LEU ILE ARG TYR ALA GLY TYR LYS GLN PRO ASP GLY SER SEQRES 16 B 422 THR LEU GLY ASP PRO ALA ASN VAL GLN PHE THR GLU ILE SEQRES 17 B 422 CYS ILE GLN GLN GLY TRP LYS ALA PRO ARG GLY ARG PHE SEQRES 18 B 422 ASP VAL LEU PRO LEU LEU LEU GLN ALA ASN GLY ASN ASP SEQRES 19 B 422 PRO GLU LEU PHE GLN ILE PRO PRO GLU LEU VAL LEU GLU SEQRES 20 B 422 VAL PRO ILE ARG HIS PRO LYS PHE ASP TRP PHE LYS ASP SEQRES 21 B 422 LEU GLY LEU LYS TRP TYR GLY LEU PRO ALA VAL SER ASN SEQRES 22 B 422 MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER ALA CYS SEQRES 23 B 422 PRO PHE SER GLY TRP TYR MET GLY THR GLU ILE GLY VAL SEQRES 24 B 422 ARG ASP TYR CYS ASP ASN SER ARG TYR ASN ILE LEU GLU SEQRES 25 B 422 GLU VAL ALA LYS LYS MET ASP LEU ASP MET ARG LYS THR SEQRES 26 B 422 SER SER LEU TRP LYS ASP GLN ALA LEU VAL GLU ILE ASN SEQRES 27 B 422 ILE ALA VAL LEU TYR SER PHE GLN SER ASP LYS VAL THR SEQRES 28 B 422 ILE VAL ASP HIS HIS SER ALA THR GLU SER PHE ILE LYS SEQRES 29 B 422 HIS MET GLU ASN GLU TYR ARG CYS ARG GLY GLY CYS PRO SEQRES 30 B 422 ALA ASP TRP VAL TRP ILE VAL PRO PRO MET SER GLY SER SEQRES 31 B 422 ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR ARG SEQRES 32 B 422 LEU THR PRO SER PHE GLU TYR GLN PRO ASP PRO TRP ASN SEQRES 33 B 422 THR HIS VAL TRP LYS GLY HET HEM A 750 43 HET H4B A 760 17 HET 7F5 A 800 25 HET ACT A 860 4 HET HEM B 750 43 HET H4B B 760 17 HET 7F5 B 800 25 HET ACT B 860 4 HET ZN B 900 1 HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM ZN ZINC ION HETNAM 7F5 3-(3-FLUOROPHENYL)-N-{2-[2-(5-METHYL-1H- HETNAM 2 7F5 IMIDAZOL-1-YL)PYRIMIDIN-4-YL]ETHYL}PROPAN-1- HETNAM 3 7F5 AMINE HETNAM ACT ACETATE ION HETSYN HEM HEME FORMUL 3 H4B 2(C9 H15 N5 O3) FORMUL 4 HEM 2(C34 H32 FE N4 O4) FORMUL 5 ZN ZN 2+ FORMUL 6 7F5 2(C19 H22 F N5) FORMUL 7 ACT 2(C2 H3 O2 1-) FORMUL 8 HOH *348(H2 O) HELIX 1 1 THR A 315 SER A 320 5 6 HELIX 2 2 THR A 350 ILE A 369 1 20 HELIX 3 3 SER A 374 SER A 392 1 19 HELIX 4 4 LYS A 397 ASN A 411 1 15 HELIX 5 5 GLY A 417 TRP A 421 5 5 HELIX 6 6 THR A 434 ASN A 451 1 18 HELIX 7 7 LYS A 452 ASN A 454 5 3 HELIX 8 8 ASN A 498 GLY A 509 1 12 HELIX 9 9 PRO A 537 VAL A 541 5 5 HELIX 10 10 PHE A 551 GLY A 558 5 8 HELIX 11 11 MET A 589 VAL A 595 1 7 HELIX 12 12 VAL A 595 ASP A 600 1 6 HELIX 13 13 ILE A 606 ASP A 615 1 10 HELIX 14 14 LYS A 620 SER A 623 5 4 HELIX 15 15 LEU A 624 ASP A 644 1 21 HELIX 16 16 ASP A 650 GLY A 670 1 21 HELIX 17 17 ASP A 675 VAL A 680 1 6 HELIX 18 18 SER A 684 THR A 688 5 5 HELIX 19 19 THR A 688 HIS A 692 5 5 HELIX 20 20 ASP A 709 HIS A 714 1 6 HELIX 21 21 THR B 315 SER B 320 5 6 HELIX 22 22 THR B 350 ILE B 369 1 20 HELIX 23 23 SER B 374 SER B 392 1 19 HELIX 24 24 LYS B 397 ASN B 411 1 15 HELIX 25 25 GLY B 417 TRP B 421 5 5 HELIX 26 26 THR B 434 ASN B 451 1 18 HELIX 27 27 LYS B 452 ASN B 454 5 3 HELIX 28 28 ASN B 498 GLY B 509 1 12 HELIX 29 29 PRO B 537 VAL B 541 5 5 HELIX 30 30 PHE B 551 GLY B 558 5 8 HELIX 31 31 MET B 589 VAL B 595 1 7 HELIX 32 32 VAL B 595 ASP B 600 1 6 HELIX 33 33 ILE B 606 MET B 614 1 9 HELIX 34 34 LYS B 620 SER B 623 5 4 HELIX 35 35 LEU B 624 ASP B 644 1 21 HELIX 36 36 ASP B 650 GLY B 670 1 21 HELIX 37 37 ASP B 675 VAL B 680 1 6 HELIX 38 38 SER B 684 THR B 688 5 5 HELIX 39 39 ASP B 709 HIS B 714 1 6 SHEET 1 AA 2 LEU A 301 LYS A 304 0 SHEET 2 AA 2 VAL A 311 ASP A 314 -1 O LEU A 312 N VAL A 303 SHEET 1 AB 4 GLN A 425 ASP A 428 0 SHEET 2 AB 4 ALA A 458 ILE A 461 1 O ILE A 459 N PHE A 427 SHEET 3 AB 4 PHE A 584 SER A 585 -1 O SER A 585 N ALA A 458 SHEET 4 AB 4 ALA A 566 VAL A 567 -1 O VAL A 567 N PHE A 584 SHEET 1 AC 3 ARG A 473 VAL A 474 0 SHEET 2 AC 3 LEU A 522 GLN A 525 -1 O GLN A 525 N ARG A 473 SHEET 3 AC 3 GLU A 532 PHE A 534 -1 O GLU A 532 N LEU A 524 SHEET 1 AD 2 GLY A 484 LYS A 486 0 SHEET 2 AD 2 THR A 492 GLY A 494 -1 O LEU A 493 N TYR A 485 SHEET 1 AE 2 GLU A 543 PRO A 545 0 SHEET 2 AE 2 LYS A 560 TYR A 562 -1 O TRP A 561 N VAL A 544 SHEET 1 AF 3 LEU A 577 PHE A 579 0 SHEET 2 AF 3 LEU A 571 ILE A 574 -1 O LEU A 572 N PHE A 579 SHEET 3 AF 3 SER A 703 GLU A 705 -1 O SER A 703 N GLU A 573 SHEET 1 BA 2 LEU B 301 LYS B 304 0 SHEET 2 BA 2 VAL B 311 ASP B 314 -1 O LEU B 312 N VAL B 303 SHEET 1 BB 4 GLN B 425 ASP B 428 0 SHEET 2 BB 4 ALA B 458 ILE B 461 1 O ILE B 459 N PHE B 427 SHEET 3 BB 4 PHE B 584 SER B 585 -1 O SER B 585 N ALA B 458 SHEET 4 BB 4 ALA B 566 VAL B 567 -1 O VAL B 567 N PHE B 584 SHEET 1 BC 3 ARG B 473 VAL B 474 0 SHEET 2 BC 3 LEU B 522 GLN B 525 -1 O GLN B 525 N ARG B 473 SHEET 3 BC 3 GLU B 532 PHE B 534 -1 O GLU B 532 N LEU B 524 SHEET 1 BD 2 GLY B 484 LYS B 486 0 SHEET 2 BD 2 THR B 492 GLY B 494 -1 O LEU B 493 N TYR B 485 SHEET 1 BE 2 GLU B 543 PRO B 545 0 SHEET 2 BE 2 LYS B 560 TYR B 562 -1 O TRP B 561 N VAL B 544 SHEET 1 BF 3 LEU B 577 PHE B 579 0 SHEET 2 BF 3 LEU B 571 ILE B 574 -1 O LEU B 572 N PHE B 579 SHEET 3 BF 3 SER B 703 GLU B 705 -1 O SER B 703 N GLU B 573 LINK SG CYS A 415 FE HEM A 750 1555 1555 2.44 LINK FE HEM A 750 N01 7F5 A 800 1555 1555 2.33 LINK SG CYS B 415 FE HEM B 750 1555 1555 2.54 LINK FE HEM B 750 N01 7F5 B 800 1555 1555 2.27 LINK ZN ZN B 900 SG CYS A 331 1555 1555 2.41 LINK ZN ZN B 900 SG CYS B 326 1555 1555 2.46 LINK ZN ZN B 900 SG CYS A 326 1555 1555 2.33 CISPEP 1 THR A 701 PRO A 702 0 2.98 CISPEP 2 THR B 701 PRO B 702 0 -3.36 SITE 1 AC1 18 TRP A 409 ALA A 412 ARG A 414 CYS A 415 SITE 2 AC1 18 VAL A 416 SER A 457 PHE A 584 SER A 585 SITE 3 AC1 18 TRP A 587 TRP A 678 PHE A 704 TYR A 706 SITE 4 AC1 18 H4B A 760 7F5 A 800 ACT A 860 HOH A2155 SITE 5 AC1 18 HOH A2156 HOH A2157 SITE 1 AC2 17 SER A 334 MET A 336 ARG A 596 VAL A 677 SITE 2 AC2 17 TRP A 678 HEM A 750 HOH A2014 HOH A2123 SITE 3 AC2 17 HOH A2125 HOH A2144 HOH A2156 HOH A2158 SITE 4 AC2 17 TRP B 676 PHE B 691 HIS B 692 GLN B 693 SITE 5 AC2 17 GLU B 694 SITE 1 AC3 10 MET A 336 LEU A 337 GLN A 478 PRO A 565 SITE 2 AC3 10 ALA A 566 VAL A 567 PHE A 584 GLU A 592 SITE 3 AC3 10 HEM A 750 TRP B 306 SITE 1 AC4 3 TRP A 587 VAL A 649 HEM A 750 SITE 1 AC5 16 TRP B 409 ARG B 414 CYS B 415 PHE B 584 SITE 2 AC5 16 SER B 585 GLY B 586 TRP B 587 GLU B 592 SITE 3 AC5 16 TRP B 678 PHE B 704 TYR B 706 H4B B 760 SITE 4 AC5 16 7F5 B 800 HOH B2147 HOH B2182 HOH B2187 SITE 1 AC6 15 TRP A 676 PHE A 691 HIS A 692 GLN A 693 SITE 2 AC6 15 GLU A 694 SER B 334 MET B 336 ARG B 596 SITE 3 AC6 15 VAL B 677 TRP B 678 HEM B 750 HOH B2013 SITE 4 AC6 15 HOH B2158 HOH B2179 HOH B2187 SITE 1 AC7 10 TRP A 306 MET B 336 LEU B 337 GLN B 478 SITE 2 AC7 10 PRO B 565 ALA B 566 VAL B 567 GLU B 592 SITE 3 AC7 10 TYR B 706 HEM B 750 SITE 1 AC8 5 GLN B 420 TRP B 587 VAL B 649 HOH B2056 SITE 2 AC8 5 HOH B2168 SITE 1 AC9 4 CYS A 326 CYS A 331 CYS B 326 CYS B 331 CRYST1 51.650 111.540 164.440 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019361 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008965 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006081 0.00000 MASTER 483 0 9 39 32 0 28 6 0 0 0 66 END